ES2139647T3 - Composicion analgesica pulverizable y metodo de su empleo. - Google Patents

Composicion analgesica pulverizable y metodo de su empleo.

Info

Publication number
ES2139647T3
ES2139647T3 ES93900844T ES93900844T ES2139647T3 ES 2139647 T3 ES2139647 T3 ES 2139647T3 ES 93900844 T ES93900844 T ES 93900844T ES 93900844 T ES93900844 T ES 93900844T ES 2139647 T3 ES2139647 T3 ES 2139647T3
Authority
ES
Spain
Prior art keywords
spray composition
analgesic
analgesic spray
pulverizable
absorbed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900844T
Other languages
English (en)
Inventor
Joseph A Deihl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayor Pharmaceutical Laboratories Inc
Original Assignee
Mayor Pharmaceutical Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayor Pharmaceutical Laboratories Inc filed Critical Mayor Pharmaceutical Laboratories Inc
Application granted granted Critical
Publication of ES2139647T3 publication Critical patent/ES2139647T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA COMPOSICION ANALGESICA PULVERIZABLE QUE CONTIENE UN COMPUESTO ANALGESICO QUE ES ABSORBIDO EN LA SANGRE A TRAVES DE LA MUCOSA BUCAL Y UN PORTADOR LIQUIDO FARMACOLOGICAMENTE ACEPTABLE.
ES93900844T 1992-12-04 1992-12-04 Composicion analgesica pulverizable y metodo de su empleo. Expired - Lifetime ES2139647T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1992/010452 WO1994013280A1 (en) 1992-12-04 1992-12-04 Sprayable analgesic composition and method of use

Publications (1)

Publication Number Publication Date
ES2139647T3 true ES2139647T3 (es) 2000-02-16

Family

ID=22231593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900844T Expired - Lifetime ES2139647T3 (es) 1992-12-04 1992-12-04 Composicion analgesica pulverizable y metodo de su empleo.

Country Status (6)

Country Link
EP (1) EP0627915B1 (es)
JP (1) JPH07506839A (es)
AU (1) AU685741B2 (es)
DE (1) DE69230151T2 (es)
ES (1) ES2139647T3 (es)
WO (1) WO1994013280A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
WO1997038662A2 (en) * 1996-04-12 1997-10-23 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
ES2293875T3 (es) 1997-10-01 2008-04-01 Novadel Pharma Inc. Aerosol bucal no polar.
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
HUP0202797A3 (en) * 1999-09-29 2004-05-28 Procter & Gamble Compositions having improved stability
JP5577021B2 (ja) 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
MX338746B (es) 2009-08-14 2016-04-29 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
CA2913543C (en) * 2013-05-29 2024-01-09 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2975097A (en) * 1957-11-13 1961-03-14 Modern Lab Inc Topical analgesic composition
US3560625A (en) * 1967-02-20 1971-02-02 Colgate Palmolive Co Method of,and formulations for,introducing alkoxybenzamides into the systemic circulatory system
AU8533582A (en) * 1981-07-10 1984-01-12 Reckitt & Colman Products Limited Stable solutions of buprenorphine
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
JP2524709B2 (ja) * 1985-09-26 1996-08-14 塩野義製薬株式会社 鎮痛消炎作用増強剤
NL9000237A (nl) * 1990-01-31 1991-08-16 Re Novative Drugs For Dermatol Topicale farmaceutische composities voor de mondholte en vagina.
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels

Also Published As

Publication number Publication date
AU685741B2 (en) 1998-01-29
JPH07506839A (ja) 1995-07-27
DE69230151T2 (de) 2000-03-09
WO1994013280A1 (en) 1994-06-23
EP0627915B1 (en) 1999-10-13
DE69230151D1 (de) 1999-11-18
EP0627915A4 (en) 1996-02-07
AU3237393A (en) 1994-07-04
EP0627915A1 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
ES2139647T3 (es) Composicion analgesica pulverizable y metodo de su empleo.
MX9405219A (es) Nueva formulacion farmaceutica.
DE59911203D1 (de) Flüssiges zahnreinigungsgel
DK0814784T3 (da) Anvendelse af NSAID'er til behandling af pladecellecarcinomer i mundhulen eller pars oralis pharyngis
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
MX9205389A (es) Composicion farmaceutica que contiene felbinac.
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
DK0947584T3 (da) Loxoprofen-indeholdende præparat til udvortes brug
EP0701816A3 (en) Percutaneous absorption preparation containing isosolidine nitrate
ES2119800T3 (es) Mejora de la penetracion de formulaciones de aplicacion topica.
DK0768867T3 (da) Doseringsform til indgivelse af lægemiddel i væskeformig formulering
CA2148652A1 (fr) Utilisation d'un antagoniste de substance p dans une composition cosmetique et composition obtenue
MX9306988A (es) Antagonistas de bradicinina y composicion farmaceutica que los comprende.
SI0916347T1 (en) Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
ATE15596T1 (de) Pharmazeutische mittel.
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
MA22343A1 (fr) Compositions type massepain, contenant du psyllium
MY103434A (en) Antitussive liquide compositions containing phenol
ATE152354T1 (de) Protein c-haltige pharmazeutische präparation als mittel gegen entzündungen
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
FR2634825B1 (fr) Pompe a precompression pour la diffusion d'un liquide
CO4920218A1 (es) Agentes terapeuticos con base en idoxifeno, utiles en el tratamiento de la osteoporosis

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 627915

Country of ref document: ES